Clinical Trials Browser

Has results × Immunoglobulin Light-chain Amyloidosis × Flow Cytometry × Clear all

NCT00520767 2023-12-22

Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease

Phase 2 Completed

35 enrolled 7 charts

Immunoglobulin Light-chain Amyloidosis